Literature DB >> 34365033

An antisense circular RNA circSCRIB enhances cancer progression by suppressing parental gene splicing and translation.

Jian Ma1, William W Du1, Kaixuan Zeng1, Nan Wu1, Ling Fang2, Juanjuan Lyu1, Albert J Yee1, Burton B Yang3.   

Abstract

Circular RNAs (circRNAs) represent a large group of non-coding RNAs that are widely detected in mammalian cells. Although most circRNAs are generated in a sense orientation, there is a group of circRNAs that are synthesized in an antisense orientation. High-throughput analysis of breast cancer specimens revealed a significant enrichment of 209 antisense circRNAs. The tumor suppressor SCRIB was shown to potentially produce thirteen circRNAs, three of which are in an antisense orientation. Among these three circRNAs, circSCRIB (hsa_circ_0001831) was the most enriched in the breast cancer panel. This antisense SCRIB circRNA was shown to span one intron and two exons. We hypothesized that this circRNA could decrease pre-mRNA splicing and mRNA translation. To test this, we generated a hsa_circ_0001831 expression construct. We found that there was decreased SCRIB mRNA production but increased cancer cell proliferation, migration, and invasion. In comparison, an exonic sequence construct did not affect mRNA splicing but decreased protein translation, leading to increased E-cadherin expression and decreased expression of N-cadherin and vimentin. Thus, there was increased cell migration, invasion, proliferation, colony formation, and tumorigenesis. Our study suggests a novel modulatory role of antisense circRNAs on their parental transcripts. This may represent a promising approach for developing circRNA-directed therapy.
Copyright © 2021 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SCRIB; antisense; circSCRIB; circular RNA; invasion; migration; pre-mRNA; proliferation; splicing; tumorigenesis

Mesh:

Substances:

Year:  2021        PMID: 34365033      PMCID: PMC8417507          DOI: 10.1016/j.ymthe.2021.08.002

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   12.910


  64 in total

1.  Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis.

Authors:  W Yang; W W Du; X Li; A J Yee; B B Yang
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

2.  Circular Noncoding RNA NR3C1 Acts as a miR-382-5p Sponge to Protect RPE Functions via Regulating PTEN/AKT/mTOR Signaling Pathway.

Authors:  Xue Chen; Chao Jiang; Ruxu Sun; Daidi Yang; Qinghuai Liu
Journal:  Mol Ther       Date:  2020-01-15       Impact factor: 11.454

3.  Circular RNAs are abundant, conserved, and associated with ALU repeats.

Authors:  William R Jeck; Jessica A Sorrentino; Kai Wang; Michael K Slevin; Christin E Burd; Jinze Liu; William F Marzluff; Norman E Sharpless
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

4.  The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence.

Authors:  David G Hicks; Bagi R Janarthanan; Ramya Vardarajan; Swati A Kulkarni; Thaer Khoury; Daniel Dim; G Thomas Budd; Brian J Yoder; Raymond Tubbs; Marshall T Schreeder; Noel C Estopinal; Rodney A Beck; Yanling Wang; Brian Z Ring; Robert S Seitz; Douglas T Ross
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

Review 5.  Circular RNAs: Expression, localization, and therapeutic potentials.

Authors:  Qiwei Yang; Feiya Li; Alina T He; Burton B Yang
Journal:  Mol Ther       Date:  2021-01-21       Impact factor: 11.454

6.  FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.

Authors:  Muy-Teck Teh; Emilios Gemenetzidis; Deeviyaben Patel; Rameez Tariq; Ayesha Nadir; Adiam W Bahta; Ahmad Waseem; Iain L Hutchison
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

7.  The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis.

Authors:  Helen B Pearson; Edwina McGlinn; Toby J Phesse; Holger Schlüter; Anuratha Srikumar; Nathan J Gödde; Christina B Woelwer; Andrew Ryan; Wayne A Phillips; Matthias Ernst; Pritinder Kaur; Patrick Humbert
Journal:  Mol Cancer       Date:  2015-09-17       Impact factor: 27.401

8.  The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs.

Authors:  Zina Jeyapalan Rutnam; William W Du; Weining Yang; Xiangling Yang; Burton B Yang
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

9.  Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion.

Authors:  Xiangling Yang; William W Du; Haoran Li; Fengqiong Liu; Anna Khorshidi; Zina Jeyapalan Rutnam; Burton B Yang
Journal:  Nucleic Acids Res       Date:  2013-08-28       Impact factor: 16.971

10.  Translation of yes-associated protein (YAP) was antagonized by its circular RNA via suppressing the assembly of the translation initiation machinery.

Authors:  Nan Wu; Zhidong Yuan; Kevin Y Du; Ling Fang; Juanjuan Lyu; Chao Zhang; Alina He; Esra Eshaghi; Kaixuan Zeng; Jian Ma; William W Du; Burton B Yang
Journal:  Cell Death Differ       Date:  2019-05-15       Impact factor: 15.828

View more
  8 in total

1.  High-throughput analysis of ANRIL circRNA isoforms in human pancreatic islets.

Authors:  Hannah J MacMillan; Yahui Kong; Ezequiel Calvo-Roitberg; Laura C Alonso; Athma A Pai
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

2.  Promotion of tumor progression by exosome transmission of circular RNA circSKA3.

Authors:  William W Du; Xiangmin Li; Jian Ma; Ling Fang; Nan Wu; Feiya Li; Preet Dhaliwal; Weining Yang; Albert J Yee; Burton B Yang
Journal:  Mol Ther Nucleic Acids       Date:  2021-12-01       Impact factor: 8.886

Review 3.  Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma.

Authors:  Alessandro Allegra; Nicola Cicero; Alessandro Tonacci; Caterina Musolino; Sebastiano Gangemi
Journal:  Cancers (Basel)       Date:  2022-03-27       Impact factor: 6.639

Review 4.  Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook.

Authors:  Yongsheng Ruan; Libai Chen; Danfeng Xie; Tingting Luo; Yiqi Xu; Tao Ye; Xiaona Chen; Xiaoqin Feng; Xuedong Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-07       Impact factor: 6.055

Review 5.  Promising Roles of Circular RNAs as Biomarkers and Targets for Potential Diagnosis and Therapy of Tuberculosis.

Authors:  Yifan Huang; Ying Li; Wensen Lin; Shuhao Fan; Haorong Chen; Jiaojiao Xia; Jiang Pi; Jun-Fa Xu
Journal:  Biomolecules       Date:  2022-09-04

6.  Peripheral Blood circRNA Microarray Profiling Identities hsa_circ_0001831 and hsa_circ_0000867 as Two Novel circRNA Biomarkers for Early Type 2 Diabetic Nephropathy.

Authors:  Keke Zhang; Xinxing Wan; Md Asaduzzaman Khan; Xiaoying Sun; Xuan Yi; Zhouqi Wang; Ke Chen; Lin Peng
Journal:  Diabetes Metab Syndr Obes       Date:  2022-09-10       Impact factor: 3.249

Review 7.  Emerging Role and Mechanism of circRNAs in Pediatric Malignant Solid Tumors.

Authors:  Qiyang Shen; Xingyu Liu; Wei Li; Xu Zhao; Tao Li; Kai Zhou; Jianfeng Zhou
Journal:  Front Genet       Date:  2022-01-18       Impact factor: 4.599

Review 8.  Circular RNA-Is the Circle Perfect?

Authors:  Lavinia Caba; Laura Florea; Cristina Gug; Daniela Cristina Dimitriu; Eusebiu Vlad Gorduza
Journal:  Biomolecules       Date:  2021-11-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.